Cellomics Technology

Cellomics Technology

Pre-clinical
Cambridge, United StatesFounded 2019cellomicstech.com

Cellomics Technology has developed unique, innovative, and convenient tools for gene editing, especially high throughput gene editing and gene functional studies. Our innovative technology-based platforms enable us to produce an array of unique and high quality of products and provide high quality services to meet wide variety of research and drug discovery needs.

Founded
2019
Focus
AI / Machine LearningCell Therapy

About

Cellomics Technology has developed unique, innovative, and convenient tools for gene editing, especially high throughput gene editing and gene functional studies. Our innovative technology-based platforms enable us to produce an array of unique and high quality of products and provide high quality services to meet wide variety of research and drug discovery needs.

Funding History

2

Total raised: $25M

Series A$20MUndisclosedNov 15, 2022
Seed$5MUndisclosedJun 15, 2021

Company Info

TypePrivate
Founded2019
LocationCambridge, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile